Treatment
Defining the Epidemiology of a Novel GIST Multiple Tumor Syndrome: Results of a Population-Based Analysis Jason K. Sicklick, MD, Grace L. Ma, Joel M. Baumgartner,
TERAPEUTIC CONSEQUENCES FROM MOLECOLAR BIOLOGY FOR GIST PATIENTS AFFECTED BY NEUROFIBROMATOSIS TYPE 1 Mussi C, Schildhaus HU, Gronchi A, Wardelmann E,
César Serrano, Grant Eilers , Meijun Zhu, Anu Gupta, George D. Demetri ,
September, 2006
Poster Discussion III Robert G. Maki, MD PhD Memorial Hospital New York, NY, USA.
Jennie Bell CMGS/ACC Spring meeting 14 th April 2010.
